Navigation Links
CEO Addresses Fort Worth Business Leaders About Developing Pandemic and Business Continuity Plans
Date:5/16/2008

g operations as a result of an increased level of absenteeism due to illness, employees caring for the sick and social-distancing policies. In Texas alone, there is the potential for more than 6.7 million employees to be absent from their jobs, according to the Trust for America's Health report, resulting in losses of roughly $23.6 billion dollars due to absenteeism and death.

Based on his experience in working with the federal government the past several years on pandemic preparedness, Abercrombie reminded the audience that the government has asked private businesses to share in the responsibility of planning. While the federal government has plans to help slow the spread of the virus among critical populations, such as healthcare workers and emergency personnel, it is up to local communities and businesses to ensure that residents and employees stay healthy and that businesses and local economies remain up and running.

More information on how businesses can organize their own pandemic plans is available online at http://www.pandemictoolkit.com. For more information about the Trust for America's Health, visit http://healthyamericans.org/reports/flurecession/releases/TN.pdf.

About Roche

Hoffmann-La Roche Inc. (Roche), based in Nutley, N.J., is the U.S. pharmaceuticals headquarters of the Roche Group, one of the world's leading research-oriented healthcare groups with core businesses in pharmaceuticals and diagnostics. For more than 100 years in the U.S., Roche has been committed to developing innovative products and services that address prevention, diagnosis and treatment of diseases, thus enhancing people's health and quality of life. An employer of choice, in 2007 Roche was named Top Company of the Year by Med Ad News, one of the Top 20 Employers (Science) and ranked the No. 1 Company t
'/>"/>

SOURCE Hoffmann-La Roche Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Publication Addresses Misconceptions About Emergency Contraception
2. MIT researcher addresses biomedical engineering challenges
3. VaxGen Addresses MPM Claims in Letter to Stockholders
4. Free White Paper Addresses Challenges of New FDA Regulations Awaiting Combo Product Manufacturers
5. Abingworth Appoints David Mayer as Partner
6. Virgin Atlantic Selects Rolls-Royce Engines to Power Its 787 Fleet in a Deal Worth $2.6BN
7. Evotec Extends Ongoing Collaboration With CHDI Worth up to US$ 37 Million
8. ProMetic provides business update - Over $35 million worth of business secured in January
9. Vermillion Announces First Quarter 2008 Financial Results and Business Progress
10. ThromboGenics N.V. - Business Update
11. MedApps Selected as Dell-NFIB 2008 Business Excellence Award Finalist

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)..., Mass., Dec. 1 To address the eme...omote its potential, a group of individuals and co...iology Industry Association (SynBIA) in Cambridge,...ion is to provide a forum for individuals and comm...ess its opportunities and its challenges, and advo...
(Date:12/1/2009)...Ill., Dec. 1 Prairie Heart Institu...t was recently awarded two statuettes at the first...ew York City. The CLIO Healthcare Awards recognize...care advertising industry and is an extension of t... awards competitions for advertising, design and i...
(Date:12/1/2009)...ngruent Software agrees to migrate their Microsoft... clients) to Synergy Business Solutions to maintai...tle, WA (PRWEB) December 1, 2009 -- Synergy Busine...icrosoft Dynamics SL practice of Congruent Softwar...e move was necessary due to a change in Congruent ...
(Date:12/1/2009)...d NORTH VANCOUVER, British Columbia, Dec. 1 /PRNew... owned subsidiary of The Dow Chemical Company (NYS...nnounced the signing of a research and commercial ...ow AgroSciences with access to Agrisoma,s propriet...xclusive basis in major food crops, and on a non-e...
Breaking Biology Technology:Industry Forms Association to Address Opportunities and Challenges of Synthetic Biology 2Prairie Heart Institute of Illinois Wins Two CLIO Healthcare Awards 2Synergy Business Solutions Acquires the Microsoft Dynamics SL Practice of Congruent Software, Inc. 2Synergy Business Solutions Acquires the Microsoft Dynamics SL Practice of Congruent Software, Inc. 3Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 2Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 3
...oration (Nasdaq: NEOG ) announces the following ...r Results Webcast , , When: Thursday, March 19, ...onewswire.com/event.asp?id=56632 , , How: Live ...he address above. , , Contact: Terry Maynard o... are unable to participate during the live webcast...
...d on its recent analysis of the radio-frequency id...ems market, Frost & Sullivan recognizes Covidi...an Product Innovation Award for developing a contr...,s contrast delivery system combines its unit-dose...ia syringes with its RFID enabled Optivantage(TM) ...
...1, 2009 at 4:30 p.m. Eastern Time , , BOTHELL, WA... OncoGenex Pharmaceuticals, Inc. ("OncoGenex" or t...ts fourth quarter and fiscal year 2008 financial r...ided an outlook for 2009. , "2008 was a tremendous...took measures to prepare for the final stages of c...
Other Biology Technology:Frost & Sullivan Recognizes Covidien for Its CT Contrast Delivery System With RFID Enabled Intelligence 2Frost & Sullivan Recognizes Covidien for Its CT Contrast Delivery System With RFID Enabled Intelligence 3Frost & Sullivan Recognizes Covidien for Its CT Contrast Delivery System With RFID Enabled Intelligence 4OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009 2OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009 3OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009 4OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009 5OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009 6OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009 7OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009 8OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009 9OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009 10OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009 11OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009 12
(Date:12/2/2009)...es can twitch, before the thought telling it to fl...ortscalled an ion channelmust open in the surface ...l signals that spur the cell to action. New resear...hnology (NIST) has allowed scientists to observe i...rst time, potentially offering insights for future...
(Date:12/2/2009)...t at the University of Southampton,s School of Oce...graphy Centre, Southampton (NOCS) has formally des... deep sea. , Hall discovered the new species in ... of Natural History in Washington. Explaining the ...clude some of the largest crustaceans currently in...
(Date:12/1/2009)... is pleased to announce the publication of results...e efficacy and tolerability of its novel, intranas...f chronic rhinosinusitis with nasal polyps in Rhi... and European Rhinologic Societies. , Chronic r...se that can significantly reduce a patient,s quali...
Breaking Biology News(10 mins):Nervy research: Researchers take initial look at ion channels in a model system 2King crab family bigger than ever 2New data on highly effective treatment for chronic rhinosinusitis with nasal polyps 2Regence Recognized as an American Heart Association Start 21 Fit Friendly Company 61281 1Regence Recognized as an American Heart Association Start 21 Fit Friendly Company 61281 2Regence Recognized as an American Heart Association Start 21 Fit Friendly Company 61281 3State Fund Rolls Out Pandemic Planning Seminar Series 61277 1Xanodyne Expands U S Sales Force and Launches Zipsor 28TM 29 28diclofenac potassium 29 Liquid Filled Capsules 6235 1Xanodyne Expands U S Sales Force and Launches Zipsor 28TM 29 28diclofenac potassium 29 Liquid Filled Capsules 6235 2
...per published in the journal Plant Physiology pr...ols and resources available for the rapidly growin...n economically important group of plants that comp...y, apple, peach and pear. Members of this plant fa... are also the source of other desirable aesthetic ...
...n A, given to infants shortly after birth in the d...15 percent, according to a study conducted by rese...ublic Health. The study is published in the July 2...s long been known that vitamin A supplementation c...ge. Our study showed that vitamin A given at birth...
...hat patients with aggressive non-Hodgkin,s lymphom...ified chemotherapy regimen, researchers say. , At...e European Society for Medical Oncology, a group h...ports that giving these patients chemotherapy ever...roved treatment outcomes. , The standard regimen ...
Other Biology News:Review article provides tools for the Rosaceae genomics community 2Newborn vitamin A reduces infant mortality 2New treatment approach promising for lymphoma patients in the developing world 2
Rabbit Anti-NEOPTERIN Polyclonal Antibody, Unconjugated from AbD Serotec
Beagle Serum from Innovative Research
Normal Donor Donkey Serum from Equitech-Bio
X-Gal/IPTG Solution from Bioline
Biology Products: